Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 0 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Autism | 1 |
| Behavior Modification | 1 |
| Behavior Problems | 1 |
| Children | 1 |
| Drug Therapy | 1 |
| Hyperactivity | 1 |
| Literature Reviews | 1 |
| Mental Retardation | 1 |
| Metabolism | 1 |
| Outcomes of Treatment | 1 |
| Pervasive Developmental… | 1 |
| More ▼ | |
Source
| Journal of Intellectual… | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkRoy, A.; Roy, M.; Deb, S.; Unwin, G.; Roy, A. – Journal of Intellectual Disability Research, 2015
Background: ASC (autism spectrum conditions) may result from a failure of striatal beta endorphins to diminish with maturation. Many symptoms of ASC resemble behaviours induced in animals or humans by opiate administration, including decreased socialisation, diminished crying, repetitive stereotypies, insensitivity to pain and motor hyperactivity.…
Descriptors: Autism, Pervasive Developmental Disorders, Drug Therapy, Behavior Problems
